Structure−Activity Relationships and Molecular Modeling of 3,5-Diacyl-2,4-dialkylpyridine Derivatives as Selective A3 Adenosine Receptor Antagonists-Reference-Cited by-同舟云学术

Structure−Activity Relationships and Molecular Modeling of 3,5-Diacyl-2,4-dialkylpyridine Derivatives as Selective A3 Adenosine Receptor Antagonists

Published:1998-07-21 Issue:17 Volume:41 Page:3186-3201
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Li An-Hu¹,Moro Stefano¹,Melman Neli¹,Ji Xiao-duo¹,Jacobson Kenneth A.¹

Affiliation:

1. Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980093j

Reference41 articles.

1. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells

2. Adenosine A3 receptors: novel ligands and paradoxical effects

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betaketothioesters in Organocatalysis: Harnessing Nucleophilic Reactivity, the Fluorophobic Effect, and Expanding the Substrate Repertoire;Tetrahedron Chem;2024-09

2. Assay-Dependent Inverse Agonism at the A₃ Adenosine Receptor: When Neutral Is Not Neutral;ACS Pharmacology & Translational Science;2023-08-09

3. A3 Adenosine Receptor Ligands: From Discovery to Clinical Trials;Topics in Medicinal Chemistry;2023

4. Species dependence of A3 adenosine receptor pharmacology and function;Purinergic Signalling;2022-12-20

5. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities;Pharmacology & Therapeutics;2022-12